000836330 001__ 836330
000836330 005__ 20210129230943.0
000836330 020__ $$a978-3-319-42202-2
000836330 020__ $$a9783319422022 (electronic)
000836330 0247_ $$2doi$$a10.1007/978-3-319-42202-2_30
000836330 037__ $$aFZJ-2017-05451
000836330 041__ $$aEnglish
000836330 1001_ $$0P:(DE-HGF)0$$aKiessling, Fabian$$b0$$eEditor
000836330 245__ $$aImaging in Neurology Research III: Neurodegenerative Diseases
000836330 260__ $$aCham$$bSpringer International Publishing$$c2017
000836330 29510 $$aSmall Animal Imaging / Kiessling, Fabian (Editor)   ; Cham : Springer International Publishing, 2017, Chapter 30 ; ISBN: 978-3-319-42200-8 ; doi:10.1007/978-3-319-42202-2
000836330 300__ $$a761-772
000836330 3367_ $$2ORCID$$aBOOK_CHAPTER
000836330 3367_ $$07$$2EndNote$$aBook Section
000836330 3367_ $$2DRIVER$$abookPart
000836330 3367_ $$2BibTeX$$aINBOOK
000836330 3367_ $$2DataCite$$aOutput Types/Book chapter
000836330 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book$$bcontb$$mcontb$$s1501585101_13623
000836330 500__ $$aLiteraturangaben; English, Second Edition
000836330 520__ $$aPositron emission tomography (PET) plays an outstanding role among imaging technologies since it enables visualization of physiological and pathophysiological processes at the molecular level in real time. Moreover, it combines low invasiveness with high sensitivity, and numerous biological processes can be measured repeatedly and quantitatively. Therefore, it is ideally suited for translational animal research to investigate different pathologies. Especially neurodegenerative diseases are of particular interest since a plethora of imaging agents exist (Table 30.1), which allow to investigate different molecular targets involved in neurodegenerative processes. Furthermore, various animal models with neurodegenerative diseases are available, facilitating to elucidate dysfunctions associated with the progression of neurodegeneration. Above all, small animal models of Alzheimer’s and Parkinson’s disease are mainly used in this field since they are the most common pathologies of neurodegenerative diseases
000836330 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000836330 588__ $$aDataset connected to CrossRef Book
000836330 650_7 $$0(DE-588)4006617-4$$2gnd$$aBildgebendes Verfahren
000836330 650_7 $$0(DE-588)4140660-6$$2gnd$$aTiermodell
000836330 7001_ $$0P:(DE-HGF)0$$aPichler, Bernd J.$$b1$$eEditor
000836330 7001_ $$0P:(DE-HGF)0$$aHauff, Peter$$b2$$eEditor
000836330 7001_ $$0P:(DE-HGF)0$$aEndepols, Heike$$b3
000836330 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b4$$ufzj
000836330 773__ $$a10.1007/978-3-319-42202-2_30
000836330 909CO $$ooai:juser.fz-juelich.de:836330$$pVDB
000836330 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b4$$kFZJ
000836330 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000836330 9141_ $$y2017
000836330 920__ $$lyes
000836330 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000836330 980__ $$acontb
000836330 980__ $$aVDB
000836330 980__ $$aI:(DE-Juel1)INM-5-20090406
000836330 980__ $$aUNRESTRICTED